Maximilian Salcher-Konrad
Overview
Explore the profile of Maximilian Salcher-Konrad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vogler S, Knoll V, Salcher-Konrad M
Res Social Adm Pharm
. 2025 Mar;
PMID: 40074660
Background: Community pharmacy appears to have undergone considerable change over the years. Objectives: The objective of this research is to study the range of community pharmacy services provided in late...
2.
Chen F, Hu Z, Li Q, Zheng X, Li M, Salcher-Konrad M, et al.
Int J Geriatr Psychiatry
. 2025 Feb;
40(3):e70054.
PMID: 40015952
Objectives: Family and other carers of people with dementia can potentially benefit from training and support to reduce the negative impacts of caregiving and prevent harm to care recipients. While...
3.
Vogler S, Zimmermann N, Knoll V, Salcher-Konrad M, Windisch F, Espin J, et al.
J Pharm Policy Pract
. 2025 Jan;
17(Suppl 1):2442002.
PMID: 39763616
On 25-26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented...
4.
Salcher-Konrad M, Nguyen M, Savovic J, Higgins J, Naci H
JAMA Netw Open
. 2024 Sep;
7(9):e2436230.
PMID: 39331390
Importance: Randomized clinical trials (RCTs) are widely regarded as the methodological benchmark for assessing clinical efficacy and safety of health interventions. There is growing interest in using nonrandomized studies to...
5.
Bhatt J, Brohan E, Blasco D, Oliveira D, Bakolis I, Comas-Herrera A, et al.
BJPsych Open
. 2023 Aug;
9(5):e164.
PMID: 37650126
Background: The recent World Health Organization (WHO) blueprint for dementia research and Lancet Commission on ending stigma and discrimination in mental health has identified a gap around dementia-related measures of...
6.
Vogler S, Salcher-Konrad M, Habimana K
Expert Rev Pharmacoecon Outcomes Res
. 2023 Jul;
23(8):867-878.
PMID: 37450611
Introduction: Pharmaceutical systems are frequently characterized by fragmentation, and competences for outpatient and inpatient sectors sit with different authorities, payers, and purchasers. This fragmentation of responsibilities can incentivize shifting expensive...
7.
Salcher-Konrad M, Shi C, Patel D, McDaid D, Astudillo-Garcia C, Bobrow K, et al.
Int J Geriatr Psychiatry
. 2023 Jul;
38(7):e5965.
PMID: 37430439
Objectives: More people with dementia live in low- and middle-income countries (LMICs) than in high-income countries, but best-practice care recommendations are often based on studies from high-income countries. We aimed...
8.
Mata F, Oliveira D, Mateus E, Franzon A, Godoy C, Salcher-Konrad M, et al.
Dementia (London)
. 2023 May;
23(3):378-397.
PMID: 37191076
Background And Objectives: Despite the rapid increase in the number of people living with dementia in Brazil, dementia care is limited. This study describes how people living with dementia and...
9.
Davis C, Wagner A, Salcher-Konrad M, Scowcroft H, Mintzes B, Pokorny A, et al.
BMJ
. 2023 Mar;
380:e073711.
PMID: 36990506
Objective: To evaluate the frequency with which relevant and accurate information about the benefits and related uncertainties of anticancer drugs are communicated to patients and clinicians in regulated information sources...
10.
Cherla A, Mossialos E, Salcher-Konrad M, Kesselheim A, Naci H
Clin Pharmacol Ther
. 2022 Jun;
112(4):846-852.
PMID: 35662000
To address unresolved questions about drug safety and efficacy at the time of approval, the European Medicines Agency (EMA) may require that manufacturers conduct additional studies during the postmarketing period....